Intuitive Ventures Closes $150 Million Fund II
With $250 million in assets under management, the corporate venture firm’s global focus spans diagnostics, MedTech, therapies, and digital health
更多内容With $250 million in assets under management, the corporate venture firm’s global focus spans diagnostics, MedTech, therapies, and digital health
更多内容Vyrsa Technologies is a privately held medical technology company focused on a minimally invasive treatment option for patients suffering from chronic sacroiliac joint pain
更多内容to Make the Unseen Seen in Orthopedic, Neuro, and Spine Surgery
更多内容to achieve FDA 510(k) clearance of the Glean™ Urodynamics System
更多内容SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success
更多内容Innovative investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation
更多内容for precise and streamlined introduction of diagnostic and therapeutic devices into the vasculature
更多内容Focus on Technologies to Detect Lung Cancer, the Leading Cause of Cancer Deaths
更多内容helps detect and localize pneumothorax (PTX) – providing immediate notification and overlay for the presence or absence of PTX
更多内容Roche announced the official launch of the cobas® 5800 System, a new molecular laboratory instrument, in China. The cobas 5800 System helps laboratories meet the challenges of increased
更多内容